250 related articles for article (PubMed ID: 32271158)
1. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer.
Wang N; Guo W; Song X; Liu L; Niu L; Song X; Xie L
Clin Chem Lab Med; 2020 Aug; 58(9):1535-1545. PubMed ID: 32271158
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
Zhang Y; Zhang Y; Yin Y; Li S
Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
[TBL] [Abstract][Full Text] [Related]
3. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
5. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
6. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
7. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
Dong X; Chang M; Song X; Ding S; Xie L; Song X
Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
9. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P
Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397
[No Abstract] [Full Text] [Related]
11. Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.
Xia J; Luo M; Dai L; Wang L; Wang L; Zhu J
J Clin Lab Anal; 2021 May; 35(5):e23743. PubMed ID: 33682961
[TBL] [Abstract][Full Text] [Related]
12. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
[TBL] [Abstract][Full Text] [Related]
15. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
Zhang Y; Xu H
J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
[TBL] [Abstract][Full Text] [Related]
16. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
17. Circulating exosomal microRNAs as biomarkers of colon cancer.
Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
Liu W; Liu J; Zhang Q; Wei L
Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
[TBL] [Abstract][Full Text] [Related]
19. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
[TBL] [Abstract][Full Text] [Related]
20. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
